Evidence map›Paper›PMID 31198492›Full record

ArticleOxidative medicine and cellular longevity2019

Structure Characterization and Action Mechanism of an Antiaging New Compound from

Umer Farooq, Yanjun Pan, Yanfei Lin, Ying Wang, Hiroyuki Osada, Lan Xiang, Jianhua Qi

Abstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Comparative Phytochemical Analysis ofMolecules (Basel, Switzerland) · 2025
    Article
  3. Article
  4. Review
  5. Water extract fromHeliyon · 2023
    Article
  6. Article
  7. Gentirigeoside B fromAntioxidants (Basel, Switzerland) · 2022
    Article
  8. Article
  9. Oxidative medicine and cellular longevity · 2022
    Article
  10. Three Selected Edible Crops of the GenusFrontiers in pharmacology · 2021
    Review
  11. Ehretiquinone fromOxidative medicine and cellular longevity · 2021
    Article
  12. Article
  13. Gentiopicroside, a Secoiridoid Glycoside fromOxidative medicine and cellular longevity · 2020
    Article
  14. Amarogentin fromOxidative medicine and cellular longevity · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Umer FarooqCollege of Pharmaceutical Sciences, Zhejiang University, Yu Hang Tang Road 866, Hangzhou 310058, China.
Yanjun PanCollege of Pharmaceutical Sciences, Zhejiang University, Yu Hang Tang Road 866, Hangzhou 310058, China.
Yanfei LinCollege of Pharmaceutical Sciences, Zhejiang University, Yu Hang Tang Road 866, Hangzhou 310058, China.
Ying WangCollege of Pharmaceutical Sciences, Zhejiang University, Yu Hang Tang Road 866, Hangzhou 310058, China.
Hiroyuki OsadaChemical Biology Research Group, RIKEN Center for Sustainable Resource Science, Wako-shi, Saitama 351-0198, Japan.
Lan XiangCollege of Pharmaceutical Sciences, Zhejiang University, Yu Hang Tang Road 866, Hangzhou 310058, China.ORCID 0000-0001-6595-2836
Jianhua QiCollege of Pharmaceutical Sciences, Zhejiang University, Yu Hang Tang Road 866, Hangzhou 310058, China.ORCID 0000-0002-2723-1648

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A new compound, bis(4-hydroxybenzyl)ether mono-

Indexed as

AgingAntioxidantsGalactosidesGastrodiaGene Expression Regulation, FungalMalondialdehydeOxidation-ReductionOxidative StressPlant ExtractsReactive Oxygen SpeciesSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsAntioxidantsGalactosidesMalondialdehydePlant ExtractsReactive Oxygen SpeciesSaccharomyces cerevisiae Proteins

Identifiers

PMID31198492
PMCPMC6526511

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.